News & Videos - STERIS PLC IRELAND

DERBY, U.K. - February 19, 2019 - STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Raymond James Institutional Investor Conference on Monday, March 4, 2019. Michael J. Tokich, STERIS's Senior Vice President and Chief Financial Officer will present at 8:40 a.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on STERIS's investor relations website at www.steris-ir.com. About STERIS STERIS's mission is to...

Third quarter revenue grows 5% as reported and 7% on a constant currency organic basis As reported earnings per diluted share of $0.56 reflect restructuring charge of approximately $35 million Adjusted earnings per diluted share increase 13% to $1.26 DERBY, U.K. - (February 11, 2019) - STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2019 third quarter ended December 31, 2018. Revenue as reported for the quarter increased 5% to $696.2 million...

DERBY, U.K. - January 29, 2019- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2019 third quarter financial results at 10:00 a.m. Eastern Time on Tuesday, February 12, 2019. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. For those unable to...

DERBY, U.K. - December 18, 2018 - STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the J.P. Morgan Healthcare Conference on Monday, January 7, 2019. Walt Rosebrough, STERIS's President and CEO, will present at 3:00 p.m. Pacific Time. A simultaneous webcast and replay of the Company's presentation will be available on STERIS's investor relations website at www.steris-ir.com. About STERIS STERIS's mission is to help our Customers create a healthier and safer...

Approximately $45 million restructuring charge to be recorded in fiscal 2019, of which approximately $35 million is non-cash Annual profit improvement of approximately $12 million anticipated by fiscal 2021 DERBY, UK (December 4, 2018) - STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced a targeted restructuring plan, which includes the closure of two manufacturing facilities, one in Brazil and one in England, as well as other actions including product rationalization. Less than...

Second quarter revenue grows 7% as reported and 9% on a constant currency organic basis As reported EPS grows 21% and adjusted EPS grows 17% Company increases outlook for full year fiscal 2019 Company plans redomicile to Ireland DERBY, U.K. - (November 6, 2018) - STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2019 second quarter ended September 30, 2018. Revenue as reported for the quarter increased 7% to $679.0 million compared with $634.2...

DERBY, U.K. - October 23, 2018 - STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Stephens NY Investment Conference on Wednesday, November 7, 2018. Michael J. Tokich, STERIS's Senior Vice President and Chief Financial Officer, will present at 1:45 p.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on STERIS's investor relations website at www.steris-ir.com. About STERIS STERIS's mission is to help our...

DERBY, U.K. - October 23, 2018- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2019 second quarter financial results at 10:00 a.m. Eastern Time on Tuesday, November 6, 2018. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. For those unable to...

First quarter revenue grows 5% As reported EPS grows 21% and adjusted EPS grows 18% Board approves increase in quarterly dividend to $0.34 per share Fiscal 2019 full year revenue and adjusted earnings outlook confirmed DERBY, U.K. - (August 8, 2018) - STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2019 first quarter ended June 30, 2018. Fiscal 2019 first quarter revenue as reported increased 5% to $638.8 million compared with $608.0 million in...

DERBY, U.K. - July 25, 2018- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2019 first quarter financial results at 10:00 a.m. Eastern Time on Wednesday, August 8, 2018. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1- 877-317-6789 in the United States or 1-412-317-6789 internationally, then asking to join the conference call for STERIS plc. For those unable to...

DERBY, U.K. - June 1, 2018 - STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Goldman Sachs Global Healthcare Conference on Wednesday, June 13, 2018. Walt Rosebrough, STERIS's President and CEO, will present at 2:00 p.m. Pacific Time. A simultaneous webcast and replay of the Company's presentation will be available on STERIS's investor relations website at www.steris-ir.com. About STERIS STERIS's mission is to help our Customers create a healthier and...

John P. Wareham to retire as Chairman and Board member at the Company's 2018 Annual General Meeting of Shareholders Dr. Mohsen M. Sohi, independent Board member since 2005, expected to be appointed as Chairman Company appoints Dr. Nirav Shah to Board of Directors DERBY, U.K. - (May 9, 2018) - STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced that Chairman of the Board John P. (Jack) Wareham will not stand for re-election to the Board of Directors when his term expires on July...

Fourth quarter revenue increases 5% both on an as reported and constant currency organic basis Fourth quarter earnings improve to $0.86 per diluted share as reported ; adjusted earnings per diluted share increases 12% to $1.24 Full year fiscal 2018 earnings grow to $3.39 per diluted share as reported; adjusted earnings per diluted share increases 10% to $4.15 Fiscal 2019 expected to be another record year with double-digit earnings growth DERBY, U.K. - (May 9, 2018) - STERIS plc (NYSE: STE)...

DERBY, U.K. - April 25, 2018- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2018 fourth quarter and full year financial results at 10:00 a.m. Eastern Time on Wednesday, May 9, 2018. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1- 877-317-6789 in the United States or 1-412-317-6789 internationally, then asking to join the conference call for STERIS plc. For those...

Third quarter as reported revenue increases 2%; revenue grows 5% on a constant currency organic basis Third quarter GAAP earnings improve to $1.11 per diluted share ; adjusted earnings per diluted share increase 14% to $1.12 Fiscal 2018 earnings outlook increased Company announces $7 million one-time special bonus for U.S. employees DERBY, U.K. - (February 7, 2018) - STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2018 third quarter ended...

NEW YORK, NY / ACCESSWIRE / February 7, 2018 / STERIS plc (NYSE: STE ) will be discussing their earnings results in their Q3 Earnings Call to be held on February 7, 2018 at 10:00 AM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/2168 To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor Network Investor Network...

DERBY, U.K. - January 24, 2018- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2018 third quarter financial results at 10:00 a.m. Eastern Time on Wednesday, February 7, 2018. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1- 877-317-6789 in the United States or 1-412-317-6789 internationally, then asking to join the conference call for STERIS plc. For those unable...

DERBY, U.K. - December 14, 2017- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the J.P. Morgan Healthcare Conference on Monday, January 8, 2018. Walt Rosebrough, STERIS's President and CEO, will present at 3:30 p.m. Pacific Time. A simultaneous webcast and replay of the Company's presentation will be available on STERIS's investor relations website at www.steris-ir.com. About STERIS STERIS's mission is to help our Customers create a healthier and safer...

Second quarter as reported revenue declines 2% due to divestitures; grows 4% on a constant currency organic basis As reported and adjusted EPS grow 60% and 6%, respectively Cash from operations increases 15% in first half Fiscal 2018 outlook reconfirmed LEICESTER, U.K. - (November 1, 2017) - STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2018 second quarter ended September 30, 2017. Fiscal 2018 second quarter revenue as reported was $634.2...

NEW YORK, NY / ACCESSWIRE / November 1, 2017 / STERIS plc (NYSE: STE ) will be discussing their earnings results in their Q2 Earnings Call to be held on November 1, 2017 at 10:00 AM Eastern Time. To listen to the event live or access a replay of the call - visit: https://www.investornetwork.com/company/2168 To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor Network Investor...